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Carbapenem-resistant Acinetobacter baumannii (CRAB) presents a serious therapeutic
and infection control challenge. In this study, we investigated the epidemiological and
molecular differences of CRAB and the threatening factors for contributing to increased
CRAB infections at a hospital in western China. A total of 110 clinical isolates of
A. baumannii, collected in a recent 2-year period, were tested for carbapenem antibiotic
susceptibility, followed by a molecular analysis of carbapenemase genes. Genetic
relatedness of the isolates was characterized by multilocus sequence typing. Sixty-
seven of the 110 isolates (60.9%) were resistant to carbapenems, 80.60% (54/67) of
which carried the blaOXA 23 gene. Most of these CRAB isolates (77.62%) were classified−
as clone complex 92 (CC92), and sequence type (ST) 92 was the most prevalent STs,
followed by ST195, ST136, ST843, and ST75. One CRAB isolate of ST195 harbored
plasmid pAB52 from a Chinese patient without travel history. This plasmid contains
toxin–antitoxin elements related to adaptation for growth, which might have emerged
as a common vehicle indirectly mediating the spread of OXA-23 in CRAB. Thus, CC92
A. baumannii carrying OXA-23 is a major drug-resistant strain spreading in China. Our
findings indicate that rational application of antibiotics is indispensable for minimizing
widespread of drug resistance.
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Introduction
Acintobacter baumannii is an opportunistic Gram-negative pathogen, which has recently been
successfully spreading worldwide nosocomial infections and causing outbreaks of hospital-
acquired infections, primarily due to its prominent ability to acquire antibiotic resistance (Peleg
et al., 2008; Kempf and Rolain, 2012). A. baumannii is developing into multidrug resistant (MDR),
extensively drug resistant (XDR), and pandrug resistant (PDR) bacteria, and its adaptation to the
environment with drug resistance has previously been reported (Durante-Mangoni and Zarrilli,
2011). Carbapenems were regarded as the most powerful antibiotics because of its extremely
eﬀective antibacterial activity and low toxicity, but the emergence of carbapenem resistance in
A. baumannii has become a global concern recently (Peleg et al., 2008; Tiwari et al., 2012a,b).
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Resistance of A. baumannii to expanded-spectrum
cephalosporins and carbapenems is rapidly growing over
the years (Bradford, 2001; Peleg et al., 2008). For example,
surveillance by the CHINET project in China revealed that the
rate of resistance of A. baumannii to the carbapenem, such as
imipenem, doubled from 30.1% in 2006 to 62.8% in 2013 (Wang,
2008; Fupin et al., 2014).
Various types of β-lactam antibiotics, for example
carbapenems, contain β-lactam rings in their structures and can
be inactivated by β-lactamase enzymes. The β-lactamases are
classiﬁed into four diﬀerent molecular groups, Ambler classes A
through D, according to amino acid sequence identities (Bush
et al., 1995). Class A, C, and D (OXA enzymes) of β-lactamases
contain a catalytically active serine residue that cleaves the
lactam ring of antibiotics (Bush et al., 1995; Tiwari and Moganty,
2014). Class B of β-lactamases is a metallo-enzyme that requires
zinc for their catalytic activity, and therefore, has a completely
diﬀerent mechanism for enzyme activity (Tiwari and Moganty,
2013). Carbapenems, such as imipenem and meropenem,
have an exceedingly broad spectrum of activity and are able
to resist hydrolysis by most of the β-lactamases, including
extended-spectrum and derepressed class C chromosomal
AmpC β-lactamases (Bush et al., 1995). However, most of
the metallo-β-lactamases and a number of class A and D
β-lactamases are able to hydrolyse broad spectrum carbapenems,
such as imipenem and meropenem (Walther-Rasmussen and
Hoiby, 2006; Evans and Amyes, 2014). Thus, outbreaks of
OXA-23-producing A. baumannii have been reported from
various regions of the world (Carvalho et al., 2009). It is
generally believed that OXA-23 is responsible for carbapenem
antibiotic resistance. Previously, Liu et al. (2015) reported the
dissemination of MDR OXA-23-producing A. baumannii clones
throughout multiple cities in China, but little is known about the
molecular mechanisms of resistance to carbapenems in western
China.
The multilocus sequence typing (MLST) has been widely
applied in genotyping of bacteria, including A. baumannii
(Bartual et al., 2005). Molecular epidemiological research of
A. baumannii indicates that CC92 has played an important role in
nosocomial infection outbreak and spread nationwide (Runnegar
et al., 2010).
This study aimed to report the dissemination of A. baumannii
harboring carbapenemase genes throughout a university hospital
in western China, then identify the risk factors for carbapenem-
resistant Acinetobacter baumannii (CRAB) infections, and ﬁnally
perform a comprehensive evaluation and comparison of their
genetic diversity.
Materials and Methods
Bacteria Isolates
A total of 110 consecutive and non-duplicated A. baumannii
clinical isolates were collected from diﬀerent departments
[intensive care unit (ICU), gastroenterology, respiratory,
neurosurgery and other wards] at the First Aﬃliated Hospital of
Chengdu Medical College, Chengdu, Sichuan, China from 2012
to 2013. Isolates were identiﬁed by standard laboratory methods
and ATB New (bioMérieux, France). A. baumannii was further
veriﬁed when two PCR products were yielded as reported: a
425-bp internal control amplicon corresponding to the recA gene
of Acinetobacter spp. and the 208-bp fragment of the 16S rRNA
(Chiang et al., 2011) intergenic spacer region of A. baumannii
(Table 1). All strains were stored at –80◦C, and bacteria were
grown on tryptose agar or Mueller–Hinton broth or agar (Oxoid,
England).
Minimal Inhibitory Concentration (MIC)
The minimal inhibitory concentration (MIC) of carbapenems
including imipenem and meropenem for A. baumannii were
determined by the agar dilution method as previously described
in the guidelines from the Clinical and Laboratory Standards
Institute (CLSI, 2014). Escherichia coli ATCC25922 and
A. baumannii ATCC19606 were used as quality control strain.
The results were interpreted according to the CLSI guidelines
(CLSI, 2014), i.e., CRAB was deﬁned as an A. baumannii
isolate that was resistant to both imipenem and meropenem
(i.e., ≥8 μg/ml as resistant), whereas carbapenem-susceptible
A. baumannii (CSAB) possessed carbapenem MIC of ≤2 μg/ml
and carbapenem-intermediate A. baumannii (CIAB) has MIC of
4 μg/ml).
PCR Experiments
The genes encoding carbapenemases class A [e.g., Klebsiella
pneumoniae carbapenemase gene, blaKPC (Li et al., 2014)], class
B [e.g., the metallo-β-lactamases, blaIMP (Valenzuela et al., 2007),
blaVIM−1 (Tsakris et al., 2000), blaSIM (Ellington et al., 2007),
and blaNDM−1 (Yong et al., 2009)], class C [e.g., blaAmpC (Bou
and Martinez-Beltran, 2000)], and class D [e.g., blaOXA−23
(Woodford et al., 2006), blaOXA−24 (Woodford et al., 2006),
blaOXA−51 (Fu et al., 2010), blaOXA−58 (Netsvyetayeva et al.,
2011), and blaOXA−235 (Higgins et al., 2013)] were investigated
by polymerase chain reaction (PCR).
To prepare DNA templates, each isolate was grown on tryptose
agar (Oxoid, England) plate overnight. Two to three colonies
were suspended in 100 μl of sterile distilled water in a 1.5-ml
Eppendorf tube, and the suspension was heated at 100◦C for
15 min, followed by centrifugation at 12,000 g for 10 min to
pellet the debris. The resultant supernatant was used as the DNA
template in the PCRs, which were carried out in a 50-μl volume
containing 0.2 mM each deoxynucleotide, 0.5 μM each primer,
1.25 U of Taq polymerase, and 5 μl of 10× buﬀer (Thermo,
China). Primers (Table 1) were synthesized by Sangon Company
(Sangon, China). Reaction conditions of PCR were 94◦C for
5 min and 30 cycles of 94◦C for 30 s, 55◦C for 30 s (57◦C for
blaAmpC ampliﬁcation), and 72◦C for 30 s, followed by a ﬁnal
extension at 72◦C for 5 min.
Multilocus Sequence Typing
MLST was used to describe the genetic backgrounds of CRAB
and CSAB in all clinical isolates (Diancourt et al., 2010; Hamouda
et al., 2010; Pournaras et al., 2014). eBURST was performed to
cluster sequence types (STs) into clonal complexes (CCs) and
infer evolutionary descent. MLST was carried out as described
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TABLE 1 | Primers used in this study.
Locus Primer Oligonucleotides (5′ → 3′) Expected size (bp) Source
16S F CAT TAT CAC GGT AAT TAG TG 208 Chiang et al. (2011)
R AGA GCA CTG TGC ACT TAA G
RecA F CCT GAA TCT TCT GGT AAA AC 425 Chiang et al. (2011)
R GTT TCT GGG CTG CCA AAC ATT AC
KPC F GCT CAG GCG CAA CTG TAA GT 823 Li et al. (2014)
R GTC CAG ACG GAA CGT GGT AT
IMP F CTA CCG CAG AGT CTT TG 587 Valenzuela et al. (2007)
R AAC CAG TTT TGC CTT ACC AT
VIM-1 F AGT GGT GAG TAT CCG ACA G 261 Tsakris et al. (2000)
R ATG AAA GTG CGT GGA GAC
17SIM F TAC AAG GGA TTC GGC ATC G 570 Ellington et al. (2007)
R TAA TGG CCT GTT CCC ATG TG
NDM-1 F TCT CGA CAT GCC GGG TTT CGG 475 Yong et al. (2009)
R ACC GAG ATT GCC GAG CGA CTT
AmpC F ACT TAC TTC AAC TCG CGA CG 663 Bou and Martinez-Beltran (2000)
R TAA ACA CCA CAT ATG TTC CG
OXA-23 F GAT CGG ATT GGA GAA CCA GA 501 Woodford et al. (2006)
R ATT TCT GAC CGC ATT TCC AT
OXA-24 F CAA GAG CTT GCA AGA CGG ACT 420 Woodford et al. (2006)
R TCC AAG ATT TTC TAG CRA CTT ATA
OXA-51 F TAA TGC TTT GAT CGG CCT TG 353 Fu et al. (2010)
R TGG ATT GCA CTT CAT CTT GG
OXA-58 F TCG ATC AGA ATG TTC AAG CGC 530 Netsvyetayeva et al. (2011)
R ACG ATT CTC CCC TCT GCG C
OXA-235 F TTG TTG CCT TTA CTT AGT TGC 831 Higgins et al. (2013)
R CAA AAT TTT AAG ACG GAT CG
by Bartual et al. (2005) for all isolates. In brief, internal fragments
of seven housekeeping genes, gltA, gyrB, gdhB, recA, cpn60, gpi,
and rpoD, were ampliﬁed, puriﬁed, and sequenced (Fu et al.,
2010; Ruan et al., 2013). And eBURST (version 3, http://eburst.
mlst.net/) was used to assign STs to CCs and deﬁne the genetic
relatedness of STs with the most stringent deﬁnition of the groups
by sharing the same alleles at ≥6 of 7 loci (Feil et al., 2004).
Plasmid Conjugation, Extraction, Sequencing,
and Analysis
Plasmid conjugations were performed by using meropenem-
resistant A. baumannii as donors and an azide-resistant E. coli J53
as the recipient (MIC> 200μg/ml; Bogaerts et al., 2006). Matings
were performed as described previously (Wang et al., 2003),
and transconjugants were recovered on L-agar plates containing
meropenem (8 μg/ml) and azide (150 μg/ml).
Plasmid DNA was extracted using a Plasmid Midi Kit
(Omega, USA) according to the manufacturer’s instructions. The
plasmid was cut by EcoRI, then the fragments were ligated
to the vector pET21a. The complete sequencing work was
performed by the ABI-3730 XL system (Biosune Biotechnology
Company, Shanghai, China) and sequences were assembled by
Life Technologies (BigDye V3.1, four ﬂuorescence reagent kit).
The sequenced plasmid was annotated by the RAST server (Aziz
et al., 2008), then all of the predicted proteins were further
compared against the NCBI non-redundant protein database
using the BLASTP program. In addition, the DNAMAN software
(Lynnon Corporation, USA) was used to generate a circular map
of plasmid pAB52.
Nucleotide Sequence Accession Numbers
The complete nucleotide sequences (Supplementary Table S1) of
plasmid pAB52 in this study were submitted to GenBank with
assigned accession number KR030046.
Results
Characterization of Clinical Isolates
According to our previous study, 67 of the total 110A. baumannii
isolates exhibited resistance to carbapenems, imipenem and
meropenem, with MIC values of ≥8 μg/ml. These CRAB
isolates were from diﬀerent types of specimens including sputum
(n = 49), throat swabs (n = 5), blood (n = 1), douche (n = 4),
and others (n = 8). Epidemiological analysis of the 67 patients
with CRAB revealed that 27 were ≥70 years old, 15 were between
60 and 70 years old, 24 were between 21 and 60 years old,
and one was ≤20 years old. Among 40 males (59.7%) and 27
females (40.3%), 24 isolates were collected from the ICU, and 17
isolates were collected from the respiratory department. Clinical
characteristics of the 67 patients with CRAB are summarized in
Table 2.
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TABLE 2 | Clinical characteristics of 67 patients with Carbapenem-resistant Acinetobacter baumannii (CRAB).
Gender Total number Source Total number Department Total number
Male 40 (59.70%) Blood 1 (1.49%) Intensive care unit 24 (35.82%)
Female 27 (40.30%) Sputum 49 (73.13%) Respiratory 17 (25.37%)
Age (years) Total number Swab 5 (7.46%) Neurosurgery 9 (13.43%)
0–20 1 Secretion 5 (7.46%) Infectious diseases department 2 (2.99%)
21–50 11 Douche 4 (5.98%) Other wards 15 (22.39%)
51–60 13 Cerebrospinal fluid 2 (2.99%)
70–more 27 Other 2 (2.99%)
Expression of Carbapenemase Genes in
A. baumannii Isolates
All isolates were screened for the presence of β-lactamases genes
(Table 3). In the 67 CRAB isolates, all of them were positive
to recA, 16S rRNA conservative region and blaOXA−51. The
major carbapenemase gene blaOXA−23 was detected in 80.60%
of all isolates. In addition, 65 isolates (97.10%) were found
to carry blaAmpC. Other β–lactamase genes including blaKPC,
blaIMP, blaVIM−1, blaSIM, blaNDM−1, blaOXA−24, blaOXA−58, and
blaOXA−235 were undetectable in all isolates. Thus, the expression
of blaOXA−23 is still the dominant carbapenem resistance
mechanism inA. baumannii among the isolates investigated aside
from the inherent blaOXA−51 gene. One susceptible isolate carried
blaOXA−72.
Genetic Analysis of STs
To investigate whether the isolates were genetically related,
MLST was performed to characterize the CRAB, CIAB and
CSAB (Figure 1). Each ST was represented by a dot that was
proportionally sized to the number of A. baumannii containing
that ST. The MLST analysis revealed a total of 32 diﬀerent STs
in 67 CRAB, including 6 existing STs and 26 novel STs. 77.62%
of the 67 CRAB isolates were classiﬁed to CC92, ST92 and
its 4 novel single-locus variants (SLVs), ST195, ST136, ST843,
and ST75, were the predominant STs, found in 34.33, 7.46,
5.97, 4.48, and 2.99% of isolates, respectively. Among these
ﬁve predominant STs, 82.35% of carbapenem-resistant isolates
carried the blaOXA−23 gene, in which ST92 is one of the most
widespread STs across the world and belongs to the CC92 in
A. baumannii MLST databases (Wang et al., 2013). Seventeen
of the 32 CRAB STs belong to CC92 (Figure 1A). In this study,
the number of polymorphic sites in gpi (n = 8), rpoD (n = 4),
cpn60 (n = 3), recA (n = 2), and the other three loci (gdhB, gyrB,
and gltA) indicated that all were the same in CC92. Seven of the
eight CIAB were CC92 (Figure 1B), but only 3 of the 35 CSAB
were CC92 (Figure 1C). All these suggested that CC92 represents
the most widely distributed carbapenem-resistant CC identiﬁed
in the hospital.
Plasmid Analysis
To detect the nosocomial infection mediated by A. baumannii
plasmid DNA, a plasmid conjugation assay was performed.
However, none of the carbapenem-resistant isolates transferred
plasmids from A. baumannii isolates to E. coli J53 successfully.
This could be due to multiple reasons. Carbapenem resistance
genes were located in the genome, and plasmids were not
conjugative or unable to replicate in the E. coli host. Of note,
with no. 52 CRAB isolate (which harbored pAB52 plasmid)
as the donor strain, a few colonies with azide resistance and
displaying a similar morphology as the E. coli J53 recipient were
obtained from the conjugation. Yet, these colonies were found
to be arisen from A. baumannii based on the ampliﬁcation
and sequence analysis of 16S rRNA and seven housekeeping
genes gltA, gyrB, gdhB, recA, cpn60, gpi, and rpoD. Likely,
the generation of azide-resistant A. baumannii was a result of
spontaneous mutation(s). In addition, plasmid extraction assay
conﬁrmed no plasmid-containing E. coli J53 colonies, indicating
that pAB52 could not be transferred from A. baumannii to
E. coli J53.
RAST analysis showed that the plasmid pAB52 was 8,893 bp
in size and contained 10 open reading frames (ORFs; Figure 2A),
with an average G+C content of 34.5%. Three genes with a
putative role in virulence were detected in pAB52: a septicolysin-
like gene coding for a pore-forming toxin (Rosado et al., 2008;
Gan et al., 2012), a TonB-dependent receptor gene coding for an
outer membrane protein involved in iron uptake and virulence
(Acosta et al., 2011; Gan et al., 2012), and a toxin–antitoxin
(TA) gene coding for is a functional TA system and that its
toxin, SplT (Gan et al., 2012; Jurenaite et al., 2013), inhibits
translation (Figure 2A). One ORF (orf 9) codes for proteins
that share similarity to hypothetical proteins encoded by plasmid
genes found in other bacteria (Gan et al., 2012), while the
predicted products of three others (orf 1, orf 2, and orf 3) do
not match any known sequences. orf 9, which is adjacent to the
replication initiation protein, is similar to replication protein of
other genomes (Figure 2B). Therefore, it might contribute to a
replication ability. Further analysis indicated that this plasmid
TABLE 3 | Positive rates of β-lactamase genes in CRAB.
No. of strains Rate of gene (%)
KPC IMP VIM-1 SIM NDM-1 AmpC OXA-23 OXA-24 OXA-51 OXA-58 OXA-235
67 0 0 0 0 0 97.10 80.60 0 100 0 0
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FIGURE 1 | Distribution of genes in 67 Carbapenem-resistant Acinetobacter baumannii (CRAB), 8 carbapenem-intermediate A. baumannii (CIAB),
and 35 carbapenem-susceptible A. baumannii (CSAB). Minimum spanning tree analysis by eBURST algorithm of CRAB (A), CIAB (B) and CSAB (C)
isolates based on MLST data. Each circle represents a specific sequence type (ST). The size of each circle homologizes to a different number of isolates, with
larger sizes representing higher frequency of occurrence. The solid lines connecting the circles indicate the relationship between different STs.
sharedmost nucleotide identity with previously described isolates
of A. baumannii, WM99C, TCDC-AB0715, AB210, AB0057,
1656-2, AYE, UMB001, and ATCC17978, Acinetobacter sp.
6013150 and 6013113 (Figure 2B).
Discussion
Clinical characterization of 67 patients with CRAB indicated
that compromised immunity (e.g., elderly patients suﬀering
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FIGURE 2 | (A) Diagram of plasmid pAB52 (GenBank accession number KR03004). The open reading frames (ORFs), represented by arrows pointing in the
direction of transcription, are white, except for that for the reported genes, which is black. (B) Comparative analysis of the genetic environment of the
TonB-dependent receptor in plasmid DNA by RAST software. Regions with 100% nucleotide sequence identity or similar biological function are filled with the
same pattern.
from respiratory failure, encephalorrhagia, extensive burns, and
chronic obstructive pulmonary disease) increases the risk of
A. baumannii infection. In addition, males appear to have a
greater risk of infection than females.
Surveillance by the CHINET project demonstrated that the
A. baumannii rate of imipenem resistance increased over twofold
between 2006 and 2013 to 62.8% in China (Fupin et al.,
2014). In contrast, the resistance rate of Acinetobacter spp. to
cefoperazone/sulbactam was only 36.4% (Fupin et al., 2014),
far below the rates of imipenem resistance. Mirroring the
national trend, theA. baumannii resistance rate of imipenem and
cefoperazone/sulbactamat in our hospital was 60.9 and 14.75%,
respectively (Ying et al., 2013).
We observed that OXA-23 was also the major carbapenemase
mechanism responsible for the resistance phenotype (Table 3),
as the gene was expressed in most CRAB isolates. This result
is consistent with previous reports in which the CRAB is often
caused due to the expression of OXA enzymes, particularly
OXA-23 (Fu et al., 2010; Merino et al., 2014; Zowawi et al.,
2015).
In our experiments, we unexpectedly found one particular
carbapenem-susceptible isolate, which belonged to ST220 and
carried the blaOXA−72 gene, a member of the blaOXA−24
subgroup, but this isolate did not carry any other resistance
genes. This is the ﬁrst time that blaOXA−24 has been detected
in western China. Of note, this isolate was not only susceptible
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to meropenem and imipenem, but also susceptible to other
β-lactams, aminoglycosides, tetracyclines, ﬂuoroquinolone,
rifampicin, and trimethoprim–sulfamethoxazole (data not
shown). Our results are in contrast with previous reports
that nosocomial infections were triggered by CRAB-carrying
plasmids encoding OXA-72 carbapenemase via plasmid DNA
from Lithuanian (Povilonis et al., 2013) and Taiwan (Lu et al.,
2009). There are several possible reasons for the diﬀerent
results. For instance, the resistance genes may not get expressed
because of diﬀerent or changed genetic environment. Further
investigation is needed why the presence of blaOXA−72 does not
produce β-lactam resistance.
MLST is an unambiguous and utility technique that identiﬁes
accurate and portable nucleotide sequences of internal fragments
from multiple loci housekeeping genes and was used to assess
the genetic background of populations in an ocean of bacteria
(Maiden et al., 1998). Based on our existing epidemiological
data and the eBURST arithmetic, it was shown that CC92 was
widespread and this major clone was resistant to carbapenem
antibiotics in our hospital. Ruan et al. (2013) explained that
CC92 is a widespread variant that has advantages with respect
to acquiring resistance determinants and surviving in the
nosocomial environment, which renders it preferentially selected
under antibiotic pressure. This may be the primary reason for
the current epidemiological situation of CC92 in our study. In
addition, 82.35% of CRAB from the ﬁve predominant STs in
CC92 carried the blaOXA−23 gene.We propose that the blaOXA−23
gene is tied to the genetic background of CC92, representing
an important setting in which to study the emergence of
carbapenem resistance. A novel SLVs of CC92, ST843 was
identiﬁed in three isolates, and sharing six same alleles with
ST92 and n1 (Figure 1A). We could infer that it may be
one of the evolutions of A. baumannii to adapt nosocomial
environment.
We used eBURST to analyze the distribution of the STs of
CSAB, and found it was more dispersive than the distribution
of CRAB (Figure 1). This may conﬁrm that CSAB has a
more diverse genetic background compared to CRAB. The high
genetic diversity in CSAB might be attributed to the decreased
survival rate of antibiotic treatment. None of them emerge
more than once among 35 carbapenem-susceptible isolates from
May 2012 to October 2013 except for 3 isolates belonging to
CC92. These data also imply that CSAB may have a more
diverse genetic source compared to the CRAB, and suggest CC92
is an evolution for A. baumannii to survive while antibiotics
existed.
We also observed that a few A. baumannii isolates could
acquire azide resistance after the bacteria were mixed and
incubated with E. coli J53 together overnight. This can be
totally expected since spontaneous mutation(s) conferring
azide resistance could arise and be selected in the presence
of azide, similar to those in vitro selections of drug-
resistant mutants. This can be considered as a process of
adaptation to a selection pressure. Indeed, mutations conferring
resistance to azide have been reported in both E. coli
(Fortin et al., 1990) and Acinetobacter spp. (Elkeles et al.,
1994).
The cryptic plasmid pAB52 from CRAB isolate no. 52 does
not carry any carbapenem resistance genes. It matches best with
pAC12 which was reported in 2012 in Malaysia (Gan et al., 2012),
and the ST of this pAB52 CRAB is ST195 (1-3-3-2-2-96-3) in
parallel with A. baumannii AC12. According to the results of
pAB52 sequence blast in NCBI (date not shown), all plasmids
carry the same genes with over 99.9% identity over the full
length, and belong to the A. baumannii plasmid group (GenBank
accession number CP008850, CP007535, CP007550, CP001183,
CP007578, KJ586856, KJ477078, and CP006964). Thus, plasmid
pAB52 is larger with an additional segment of TonB gene
(Figure 2B), but these plasmids may have the same function. For
example, the septicolysin-like protein encoded in these plasmids
suggests that it may be involved in survival of bacteria in the
lungs and blood (Acosta et al., 2011). The TA systems have been
suggested to mediate bacterial persistence by generating slowly
growing cells tolerant to antibiotics and environmental changes
(Jurenaite et al., 2013). In particular, the pAB52-containing strain
was isolated from the sputum of a 74-year-old male who lived in
a rural district in western China and had not traveled to any areas
before admission to the hospital’s ICU. This individual was found
to have acquired an XDR A. baumannii infection during his
hospital stay and eventually, he died from respiratory failure. The
observation suggests that probably plasmid-borne A. baumannii
TA systems contribute for the evolution of antibiotic resistance in
this opportunistic pathogen.
In summary, this investigation conﬁrms that the CC92
producing blaOXA−23 was the leading reason for the dramatic
increase in the carbapenem resistance rates in China. Awareness
of carbapenem-resistant organisms and their development in
hospitals has crucial implications in optimizing infection control
practices, establishing antimicrobial stewardship programs
within the hospital, and ﬁnally establishing active regional
surveillance systems (Zowawi et al., 2015).
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